FDA Finds Impurity In Suspect Heparin Batches

Law360, New York (March 19, 2008, 12:00 AM EDT) -- Federal regulators have identified a contaminant in batches of heparin linked to 19 deaths and hundreds of allergic reactions in the U.S. and are working to figure out how the blood thinner got contaminated.

In a press conference Wednesday, the U.S. Food and Drug Administration identified the contaminant as oversulfated chondroitin sulfate, a chemically altered form of chondroitin sulfate.

Tests on heparin batches originating from China have shown that the contaminant accounts for as much as 50% of the active ingredient.

While chondroitin sulfate is naturally...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.